Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
1.040
-0.040 (-3.70%)
Dec 27, 2024, 4:00 PM EST - Market closed

Century Therapeutics Revenue

Century Therapeutics had revenue of $791.00K in the quarter ending September 30, 2024, with 434.46% growth. This brings the company's revenue in the last twelve months to $2.68M, up 7.88% year-over-year. In the year 2023, Century Therapeutics had annual revenue of $2.24M, down -57.01%.

Revenue (ttm)
$2.68M
Revenue Growth
+7.88%
P/S Ratio
28.01
Revenue / Employee
$16,267
Employees
165
Market Cap
88.43M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.24M-2.96M-57.01%
Dec 31, 20225.20M--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CytomX Therapeutics 126.62M
Assertio Holdings 125.76M
Exagen 55.75M
Adlai Nortye 5.00M
Adagene 815.75K
Monogram Technologies 365.00K
Zentek 29.13K
Revenue Rankings